FOLD- Amicus Therapeutics, Inc.

Name: Amicus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Campbell Bradley L	1.02M	$14.80M	-
Other	Rosenberg Ellen	464.6K	$6.73M	-
Other	Castelli Jeff	409.3K	$5.93M	-
Other	Clark David Michael	221.8K	$3.21M	-
CFO	Harford Simon N.R.	143.6K	$2.08M	-

Activity

Buys and sells only

Transactions

10 filings · page 17

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 15, 2021	Crowley John F67	Chairman &CEO	Sale+OE	22,000	$10.77	$236,988.40	-2.6%	-0.7%	-17.1%
Mar 1, 2021	Crowley John F67	Chairman &CEO	Sell	7,500	$11.85	$88,881.00	-0.9%	-	-
Mar 1, 2021	Campbell Bradley L66	Chief Operating Officer	Sale+OE	10,514	$11.84	$124,516.25	-2.7%	-	-
Mar 1, 2021	Whitman Burke W50	Director	Buy	1,500	$12.40	$18,600.00	+3.6%	-	-
Feb 22, 2021	Crowley John F67	Chairman &CEO	Sell	7,682	$11.98	$92,027.29	-0.9%	-	-
Feb 16, 2021	Crowley John F67	Chairman &CEO	Sale+OE	22,000	$12.26	$269,700.20	-2.5%	-	-
Feb 1, 2021	Campbell Bradley L66	Chief Operating Officer	Sale+OE	10,514	$19.08	$200,571.37	-2.7%	-	-
Feb 1, 2021	Crowley John F67	Chairman &CEO	Sell	7,500	$19.08	$143,076.75	-0.9%	-	-
Feb 1, 2021	Whitman Burke W50	Director	Buy	1,500	$19.09	$28,636.80	+3.8%	-	-
Jan 20, 2021	Crowley John F67	Chairman &CEO	Sale+OE	72,000	$21.73	$1,564,693.00	-3.9%	-	-

← PrevPage 17Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC